Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST Registry.
Naoaki Ohkubo; Yusuke Miyazaki; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yoshino Inoue; Yurie Satoh-Kanda; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Kiyotake Yoshioka; Mayu Nishimoto; Kazuki Takahashi; Shingo Nakayamada; Yoshiya Tanaka
Modern rheumatology, Mar. 2026

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.
Takafumi Aritomi; Koshiro Sonomoto; Shingo Nakayamada; Hiroaki Tanaka; Atsushi Nagayasu; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Naoaki Ohkubo; Yasuyuki Todoroki; Yurie Satoh-Kanda; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Satsuki Matsunaga; Hiroaki Tanaka; Masayuki Shinojima; Hiroki Kawamura; Kazuki Takahashi; Miyabi Ando; Kazuki Haru; Yusuke Miyazaki; Kentaro Hanami; Masao Nawata; Shunsuke Fukuyo; Keisuke Nakatsuka; Mikiko Tokunaga; Kazuyoshi Saito; Yoshiya Tanaka
Arthritis & rheumatology (Hoboken, N.J.), Mar. 2026

Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.
Hidenori Sakai; Koshiro Sonomoto; Shingo Nakayamada; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Hiroaki Tanaka; Satoshi Kubo; Ippei Miyagawa; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Ryuichiro Kanda; Yoshiya Tanaka
RMD open, Feb. 2026

Pivotal contribution of super-enhancer-driven KLF6 expression to the adipogenesis of human adipose-derived stem cells.
Mai-Phuong Nguyen; Kaoru Yamagata; Anh Phuong Nguyen; Tong Zhang; Hidenori Sakai; Uyen Thi Ngo; Yu Shan; Takashi Otsuka; Ngo Thi Dieu Huong; Takafumi Aritomi; Meng Yuan; Shigeaki Kato; Yoshiya Tanaka; Shingo Nakayamada
Inflammation and regeneration, Jan. 2026

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry.
Koshiro Sonomoto; Shingo Nakayamada; Hidenori Sakai; Masanobu Ueno; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Makoto Okawara; Akinori Nakata; Yoshiya Tanaka
RMD open, Jan. 2026

Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.
Masanobu Ueno; Koshiro Sonomoto; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Hidenori Sakai; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Jan. 2026

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Atsushi Nagayasu; Yusuke Miyazaki; Koshiro Sonomoto; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Hiroaki Tanaka; Yasuyuki Todoroki; Masanobu Ueno; Takafumi Aritomi; Yuya Fujita; Hidenori Sakai; Katsunori Suzuki; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Aug. 2025

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Ryuichiro Kanda; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yurie Satoh-Kanda; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Yuya Fujita; Takafumi Aritomi; Katsuhide Kusaka; Hidenori Sakai; Satsuki Matsunaga; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, Apr. 2025

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Masanobu Ueno; Shigeru Iwata; Kaoru Yamagata; Yasuyuki Todoroki; Koshiro Sonomoto; Atsushi Nagayasu; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Hiroko Miyata; Ryuichiro Kanda; Takafumi Aritomi; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Dec. 2024

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Atsushi Nagayasu; Ryuichiro Kanda; Takafumi Aritomi; Satsuki Matsunaga; Masanobu Ueno; Ippei Miyagawa; Koshiro Sonomoto; Kentaro Hanami; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Dec. 2023

Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset.
Masao Nawata; Kazuki Someya; Shunpei Kosaka; Takafumi Aritomi; Masashi Funada; Yuya Fujita; Atsushi Nagayasu; Yoshihisa Fujino; Kazuyoshi Saito; Yoshiya Tanaka
Modern rheumatology, Mar. 2023

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study.
Masanobu Ueno; Ippei Miyagawa; Takafumi Aritomi; Koichi Kimura; Shigeru Iwata; Kentaro Hanami; Syunsuke Fukuyo; Satoshi Kubo; Yusuke Miyazaki; Shingo Nakayamada; Yoshiya Tanaka
Arthritis research & therapy, Jun. 2022

Rituximab in remission induction and maintenance therapy for microscopic polyangiitis associated with gastric cancer: A case report.
Takafumi Aritomi; Masao Nawata; Aya Nawata; Yoshihisa Himeno; Kazuyoshi Saito; Yoshiya Tanaka
Modern rheumatology case reports, Jun. 2022

巨細胞性動脈炎と好酸球性多発血管炎性肉芽腫症を合併した多発血管炎重複症候群の一例
有冨 貴史; 中野 和久; 河邊 明男; 今林 慶祐; 名和田 彩; 宮崎 佑介; 中山田 真吾; 田中 良哉
九州リウマチ, Sep. 2021

トシリズマブに対するInfusion Reaction後に再投与により寛解導入・維持が可能であった成人スチル病の1症例
有冨 貴史; 名和田 雅夫; 船田 将史; 齋藤 和義; 田中 良哉
九州リウマチ, Mar. 2021

強直性脊椎炎に対してTNF-α阻害薬で加療中に発症した掌蹠膿疱症の2症例
有冨 貴史; 中野 和久; 吉成 紘子; 中山田 真吾; 岩田 慈; 福與 俊介; 宮川 一平; 河邊 明男; 宮崎 佑介; 上野 匡庸; 田中 良哉
九州リウマチ, Mar. 2020

Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
Takafumi Aritomi; Takashi Kido; Kazuhisa Nakano; Yurie Satoh; Shingo Noguchi; Takanobu Jotatsu; Tetsuya Hanaka; Minoru Satoh; Yoshiya Tanaka; Kazuhiro Yatera
Internal medicine (Tokyo, Japan), Feb. 2019

消化管潰瘍を反復した骨髄異形成症候群関連結節性多発動脈炎の1例
有冨 貴史; 中野 和久; 宮川 一平; 玉城 泰太郎; 宮田 寛子; 岩田 慈; 福與 俊介; 中山田 真吾; 田中 良哉
九州リウマチ, Sep. 2018

Relapsing Polychondritis Diagnosed by Fusion Images of Gallium-67 Uptake on Computed Tomography and Single-Photon-Emission Computed Tomography.
Kazuhisa Nakano; Takafumi Aritomi; Naoaki Ohkubo; Yoshiya Tanaka
Arthritis & rheumatology (Hoboken, N.J.), Dec. 2017

強直性脊椎炎に対してTNF-α阻害薬で加療中に発症した掌蹠膿疱症の2症例
有冨 貴史, 中野 和久, 吉成 紘子, 中山田 真吾, 岩田 慈, 福與 俊介, 宮川 一平, 河邊 明男, 宮崎 佑介, 上野 匡庸, 田中 良哉
九州リウマチ, Mar. 2020, Reviewed, No invitation
Lead

無症候性IgG4関連胆嚢炎を伴ったIgG4関連疾患の一例
日下 勝秀, 中野 和久, 吉成 紘子, 岩田 慈, 福與 俊介, 花見 健太郎, 久保 智史, 宮川 一平, 河邊 明男, 宮崎 佑介, 名和田 彩, 井上 嘉乃, 上野 匡庸, 有冨 貴史, 中山田 真吾, 田中 良哉
九州リウマチ, Mar. 2019, Reviewed, No invitation

消化管潰瘍を反復した骨髄異形成症候群関連結節性多発動脈炎の1例
有冨 貴史, 中野 和久, 宮川 一平, 玉城 泰太郎, 宮田 寛子, 岩田 慈, 福與 俊介, 中山田 真吾, 田中 良哉
九州リウマチ, Sep. 2018, Reviewed, Null
Lead

Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy.
Aritomi Takafumi, Kido Takashi, Nakano Kazuhisa, Satoh Yurie, Noguchi Shingo, Jotatsu Takanobu, Hanaka Tetsuya, Satoh Minoru, Tanaka Yoshiya, Yatera Kazuhiro
Internal medicine (Tokyo, Japan), Feb. 2019, Reviewed, No invitation
Lead

Usefulness of Ultrasound as a Predictor of Elderly-Onset Rheumatoid Arthritis with Polymyalgia Rheumatica-Like Onset.
Nawata Masao, Someya Kazuki, Kosaka Shunpei, Aritomi Takafumi, Funada Masashi, Fujita Yuya, Nagayasu Atsushi, Fujino Yoshihisa, Saito Kazuyoshi, Tanaka Yoshiya
Modern rheumatology, Mar. 2022, Reviewed, No invitation

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Ueno Masanobu, Iwata Shigeru, Yamagata Kaoru, Todoroki Yasuyuki, Sonomoto Koshiro, Nagayasu Atsushi, Miyagawa Ippei, Kubo Satoshi, Miyazaki Yusuke, Miyata Hiroko, Kanda Ryuichiro, Aritomi Takafumi, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Dec. 2024, Reviewed, No invitation

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Aug. 2025, Reviewed, No invitation

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo Satoshi, Miyazaki Yusuke, Todoroki Yasuyuki, Nagayasu Atsushi, Kanda Ryuichiro, Aritomi Takafumi, Matsunaga Satsuki, Ueno Masanobu, Miyagawa Ippei, Sonomoto Koshiro, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2023, Reviewed, No invitation